HLS Therapeutics
TSX:HLS
C$ 4,59
C$-0,06 (-1,29%)
4,59 C$
C$-0,06 (-1,29%)
End-of-day quote: 04/24/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

C$-0,53
Earnings Per Share
C$2,43
Revenue Per Share
71,55%
Gross Margin %
C$0,15 B
Market Cap
C$0,06 B
Long-Term Debt
Earnings Per Share
C$-0,53
Revenue Per Share
C$2,43
Gross Margin %
71,55%
Market Cap
C$0,15 B
Long-Term Debt
C$0,06 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020 2016
EPS Earnings Per Share C$-0,53 C$-0,89 C$-0,85 C$-0,57 C$-0,40 C$-0,47 C$-0,60
Earnings Earnings C$-16,57M C$-28,29M C$-27,13M C$-18,44M C$-12,99M C$-15,04M C$-15,17M
RPS Revenue Per Share C$0,00 C$2,43 C$2,56 C$1,98 C$1,90 C$1,85 C$1,75 C$2,14
Revenue Revenue C$0,00M C$76,10M C$81,47M C$63,07M C$61,47M C$60,01M C$56,11M C$54,03M
OCF Operating Cash Flow C$0,00M C$14,26M C$11,52M C$15,79M C$16,94M C$16,43M C$9,34M C$0,00M
FCF Free Cash Flow C$0,00M C$16,18M C$11,49M C$15,00M C$16,90M C$12,56M C$9,31M C$0,00M
OM Operating Margin 0,00% -7,40% -13,57% -16,41% -21,96% -10,47% -21,54% 0,00%
GM % Gross Margin % 0,00% 71,55% 74,11% 79,08% 82,58% 83,92% 83,80% 0,00%
FCFS Free Cash Flow Per Share C$0,00 C$0,66 C$0,96 C$0,48 C$0,21 C$0,37 C$-1,11 C$0,00
LT Debt Long-Term Debt N/A C$64,00M C$87,40M C$82,05M C$83,28M C$84,13M C$98,24M C$146,04M
Sha. Stocks 33,38M 31,27M 31,79M 31,92M 32,35M 32,47M 31,99M 25,28M
×